Facebook
Twitter
LinkedIn
ForwardDEA MATE ACT for Prescribers: Evidence Based Approaches to Screen, Treat and Refer SUD Patients - And Safely Treat Pain for All
IMPORTANT:
- Attendees who only participated in the live/zoom option on December 1 should claim 6 hours of credits.
- Attendees who registered for the addition self-paced online modules will be emailed to registered participants at the conclusion of the December 1st training. Learners will have until June 30, 2024 to complete the training and submit the required post-test and evaluation to receive credit.
This course is offered in partnership with Allegany College of Maryland, AHEC West, the Allegany/Garrett Dental Association, and UPMC Western Maryland.
Learning Objectives
- Describe the biopsychosocial root causes of addiction including risks and protective factors, including epigenetics.
- Recognize drug-seeking behavior and signs of medication misuse and appropriately address patient non-compliance.
- List the FDA approved Medication Assisted Treatment options, including benefits, risks and contraindications.
- Outline the laws, regulations, and best practices related to controlled substances.
- Describe the societal impacts of the SUD crisis and the prescriber’s role in mitigating SUD risk through screening and pain management practices.
Additional Information
| Attachment | Size |
|---|---|
 DEA Mate Brochure.pdf | 947.12 KB |
This 2-part course is designed to fulfill the Medication Assisted Treatment Education (MATE) requirements set by the Drug Enforcement Administration (DEA) for health care providers and dental professionals in Section 1263 of the Consolidated Appropriations Act of 2023. This course is offered in partnership with AHEC West, the Allegany/Garrett Dental Association, and UPMC Western Maryland.
DEA MATE PART I: (AHC179/180) On Friday, December 1st, join Dr. Stephanie Hutter-Thomas for a 6-hour, multi-disciplinary course designed to meet the DEA mandate AND take participants beyond the regulations and statistics to better understand what’s really happening on the frontlines of the addiction crisis, particularly in Appalachia. The live-session will be offered in ACM’s newly renovated Zimmer Theatre or on ZOOM. Please specify AHC179 for in-person or AHC180 for ZOOM at time of registration.
Dr. Hutter-Thomas is a public health expert with a specialization in substance use and substance use disorder (SUD) research. She will share the latest information on the biopsychosocial causes and impacts of addiction as well as the various medication and non-medication options for SUD treatment and recovery. Practitioners will learn practical, sometimes covert, methods to screen for medication misuse (in their practice and at home) and evidence-based approaches to communicate with and safely treat or refer their SUD impacted patients. They will also gain techniques and confidence to support their patients (or family and friends) as they navigate recovery.
The science that drives best-practices and the laws and regulations related to controlled substances will be covered. However, Dr. Hutter-Thomas will bring this information to life through real stories of diagnosis, treatment, and recovery. She will share the latest information on risks and protective factors that influence addiction as well as current best-practices for pain management.
Upon Completion of this Course Participants should be able to:
- Describe the biopsychosocial root causes of addiction including risks and protective factors, including epigenetics.
- Recognize drug-seeking behavior and signs of medication misuse and appropriately address patient non-compliance.
- List the FDA approved Medication Assisted Treatment options, including benefits, risks and contraindications.
- Outline the laws, regulations, and best practices related to controlled substances.
- Describe the societal impacts of the SUD crisis and the prescriber’s role in mitigating SUD risk through screening and pain management practices.
DEA MATE PART II: (AHC181) 2-Hour Online Supplement for Non-Dental Prescribers
After completing the 6-hour live training, physicians, nurse practitioners, physician assistants,and other non-dental prescribers will complete a 2-hour online supplement that takes a deeper dive into treating and managing patients with opioid or other substance use disorders. This ON DEMAND course, also taught by Dr. Stephanie Hutter-Thomas, includes additional information on the appropriate clinical use of all drugs approved by the Food and Drug Administration for the treatment of SUD as well as pain management best practices. Electronic prescribing and Prescription Drug monitoring Programs will also be covered.
Upon Completion of this Course Participants should be able to:
- Implement effective pain management strategies while adhering to DEA regulations.
- Describe the role of electronic prescribing and use of the Prescription Drug Monitoring Programs (PDMPs) effectively.
- Assess and prescribe the appropriate Medication Assisted and other treatment options for their SUD patients.
The live-session will be offered in ACM’s newly renovated Zimmer Theatre. Please select the live option during the registration process.
Dr. Stephanie Hutter-Thomas, PhD, CPH, CCHW, RPS is the research program director for the Buprenorphine Implementation Research & Community Health (BIRCH) study with West Virginia University School of Medicine and an educator/consultant for the Maryland Rural Opioid Technical Assistance (MarylandROTA) program with University of Maryland Extension.
Since 2016, Dr. Hutter-Thomas has served the Western MD region as a researcher, community educator, CPRS trainer/peer mentor, and harm reduction advocate. She is actively involved in multiple community actions groups including the Healing Allegany Consortium with AHEC West, the Stand Together Garrett Coalition with the Garrett County Health Dept, and the Allegany College Community Resilience Collaborative. Dr. Hutter-Thomas is also a member of the Frostburg State University Institutional Review Board, the Allegany County Mental Health Advisory Board, the Archway Station board of directors, and the Maryland Coalition of Families board of directors.
Important Note:
- Attendees who only participated in the live/zoom option on December 1 should claim 6 hours of credits.
- Attendees who registered for the additional 2-hour self-paced online module will receive an email at the conclusion of the December 1st training. Learners will have until June 30, 2024 to complete the training and submit the required post-test and evaluation to receive credit.
In support of improving patient care, this activity has been planned and implemented by the University of Pittsburgh and Allegany Medical College. The University of Pittsburgh is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Physician (AMA)
The University of Pittsburgh designates this blended activity for a maximum of 8 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nursing (ANCC)
The maximum number of hours awarded for this Continuing Nursing Education activity is 8 contact hours.
DEA Medication Access and Training Expansion (MATE) Act
This training is designed to meet the training requirements for Medication Access and Training Expansion (MATE) Act of 2023.
Pennsylvania Opioid/Pain Management Credit (physicians only)
This activity has been designated as and qualifies for Opioid/Pain Management Credit. It is the responsibility of the learner to maintain the educational presentation or conference agenda as evidence, if needed for audit purposes
DISCLAIMERS
Allegany College of Maryland does not discriminate on the basis of age, ancestry/national origin, color, disability, gender identity/expression, marital status, race, religion, sex, or sexual orientation in matters affecting employment or in providing access to programs and activities. For inquiries related to this policy, Title IX, and ADA/504, please contact: Dr. Renee Conner, Dean of Student and Legal Affairs, Title IX Coordinator, ADA/504 Coordinator, 301-784-5206 / rconner@allegany.edu. Allegany College of Maryland is required to inform prospective and current students of important College policies. For full details on these key policies, please visit the Allegany College of Maryland website at allegany.edu/policy-mandates.
The information presented at this activity represents the views and opinions of the individual presenters, and does not constitute the opinion or endorsement of, or promotion by, the UPMC Center for Continuing Education in the Health Sciences, UPMC / University of Pittsburgh Medical Center or Affiliates and University of Pittsburgh School of Medicine. Reasonable efforts have been taken intending for educational subject matter to be presented in a balanced, unbiased fashion and in compliance with regulatory requirements. However, each program attendee must always use his/her own personal and professional judgment when considering further application of this information, particularly as it may relate to patient diagnostic or treatment decisions including, without limitation, FDA-approved uses and any off-label uses.
Available Credit
- 8.00 AMA PRA Category 1 Credit™The University of Pittsburgh School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.
- 8.00 Opioid Education
- 8.00 ANCCUPMC Provider Unit is accredited as a provider of continuing nursing education by the American Nurses Credentialing Center’s Commission on Accreditation
- 8.00 Attendance
Price
Important Note:
- Attendees who only participated in the live/zoom option on December 1 should claim 6 hours of credits.
- Attendees who registered for the additional 2-hour self-paced online module will receive an email at the conclusion of the December 1st training. Learners will have until June 30, 2024 to complete the training and submit the required post-test and evaluation to receive credit.
FOR MORE INFORMATION:
Melanie Chapman, Director of Career and Professional Education, Allegany College of Maryland
Call 301-784-5446 or Email mchapman@allegany.edu
FOR INFORMATION ABOUT CONTINUING EDUCATION CREDITS
Email ccehs_support@upmc.edu
Allegany College of Maryland reserves right to cancel course that, in the judgement of the Center staff, does not have sufficient enrollment. The decision is usually made one week before the first scheduled class meeting, and all registrants will be notified promptly. A full refund is processed automatically.